202 related articles for article (PubMed ID: 25597375)
1. Reduced central corneal thickness in patients with isotretinoin treatment.
Yuksel N; Ozer MD; Akcay E; Ozen U; Uzun S
Cutan Ocul Toxicol; 2015; 34(4):318-21. PubMed ID: 25597375
[TBL] [Abstract][Full Text] [Related]
2. Reduced ocular surface disease index (OSDI) scores in patients with isotretinoin treatment.
Caglar C; Senel E; Sabancilar E; Durmus M
Int Ophthalmol; 2017 Feb; 37(1):197-202. PubMed ID: 27193123
[TBL] [Abstract][Full Text] [Related]
3. Changes in anterior chamber parameters with the Pentacam rotating Scheimpflug and axial length measurements by ultrasound in patients who use isotretinoin.
Cumurcu T; Sener S; Ozsoy E; Doganay S
Curr Eye Res; 2012 May; 37(5):395-8. PubMed ID: 22510008
[TBL] [Abstract][Full Text] [Related]
4. Giant cobblestone-like papillae during isotretinoin therapy.
Rosen E; Raz J; Segev F
Ocul Immunol Inflamm; 2009; 17(5):312-3. PubMed ID: 19831559
[TBL] [Abstract][Full Text] [Related]
5. Isotretinoin treatment in patients with acne vulgaris: does it impact muscle strength, fatigue, and endurance?
Yıldızgören MT; Rifaioğlu EN; Demirkapı M; Ekiz T; Micooğulları A; Şen T; Turhanoğlu AD
Cutis; 2015 Jul; 96(1):33-6. PubMed ID: 26244352
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of thyroid function tests of acne vulgaris patients treated with systemic isotretinoin.
Yıldırım N; Doğan S; Atakan N
J Dermatolog Treat; 2017 Mar; 28(2):141-144. PubMed ID: 27425198
[TBL] [Abstract][Full Text] [Related]
7. High-dose isotretinoin treatment and the rate of retrial, relapse, and adverse effects in patients with acne vulgaris.
Blasiak RC; Stamey CR; Burkhart CN; Lugo-Somolinos A; Morrell DS
JAMA Dermatol; 2013 Dec; 149(12):1392-8. PubMed ID: 24173086
[TBL] [Abstract][Full Text] [Related]
8. Role of topical dehydroepiandrosterone in ameliorating isotretinoin-induced Meibomian gland dysfunction in adult male albino rat.
Ibrahim MAA; Elwan WM
Ann Anat; 2017 May; 211():78-87. PubMed ID: 28212783
[TBL] [Abstract][Full Text] [Related]
9. Low-dose schema of isotretinoin in acne vulgaris.
Mandekou-Lefaki I; Delli F; Teknetzis A; Euthimiadou R; Karakatsanis G
Int J Clin Pharmacol Res; 2003; 23(2-3):41-6. PubMed ID: 15018017
[TBL] [Abstract][Full Text] [Related]
10. Effects of oral isotretinoin on serum folic acid levels.
Javanbakht AM; Pour HM; Tarrahic MJ
J Drugs Dermatol; 2012 Sep; 11(9):e23-4. PubMed ID: 23135667
[TBL] [Abstract][Full Text] [Related]
11. Analysis of clinical efficacy, side effects, and laboratory changes among patients with acne vulgaris receiving single versus twice daily dose of oral isotretinoin.
Ahmad HM
Dermatol Ther; 2015; 28(3):151-7. PubMed ID: 25754162
[TBL] [Abstract][Full Text] [Related]
12. The prevalence of sacroiliitis in patients with acne vulgaris using isotretinoin.
Baykal Selçuk L; Aksu Arıca D; Baykal Şahin H; Yaylı S; Bahadır S
Cutan Ocul Toxicol; 2017 Jun; 36(2):176-179. PubMed ID: 27764978
[TBL] [Abstract][Full Text] [Related]
13. Long-term effect of systemic isotretinoin on female fertility.
Cinar SL; Kartal D; Aksoy H; Cinar E; Aydin T; Öz L; İmamoğlu H; Ferahbas A; Borlu M
Cutan Ocul Toxicol; 2017 Jun; 36(2):132-134. PubMed ID: 27292185
[TBL] [Abstract][Full Text] [Related]
14. Conjunctival impression cytology, ocular surface, and tear-film changes in patients treated with systemic isotretinoin.
Karalezli A; Borazan M; Altinors DD; Dursun R; Kiyici H; Akova YA
Cornea; 2009 Jan; 28(1):46-50. PubMed ID: 19092405
[TBL] [Abstract][Full Text] [Related]
15. Oral isotretinoin for acne, adjusting treatment according to patient's response.
Ghaffarpour G; Mazloomi S; Soltani-Arabshahi R; Seyed KS
J Drugs Dermatol; 2006 Oct; 5(9):878-82. PubMed ID: 17039654
[TBL] [Abstract][Full Text] [Related]
16. High-dose isotretinoin in acne vulgaris: improved treatment outcomes and quality of life.
Cyrulnik AA; Viola KV; Gewirtzman AJ; Cohen SR
Int J Dermatol; 2012 Sep; 51(9):1123-30. PubMed ID: 22909370
[TBL] [Abstract][Full Text] [Related]
17. The effects of the systemic isotretinoin treatment on ocular surface and meibomian glands: a prospective longitudinal study.
Acar Eser N; Kocabeyoğlu S; Atakan N; Irkec M
Cutan Ocul Toxicol; 2022 Jun; 41(2):155-161. PubMed ID: 35609140
[TBL] [Abstract][Full Text] [Related]
18. Treatment of acne with intermittent and conventional isotretinoin: a randomized, controlled multicenter study.
Akman A; Durusoy C; Senturk M; Koc CK; Soyturk D; Alpsoy E
Arch Dermatol Res; 2007 Dec; 299(10):467-73. PubMed ID: 17710426
[TBL] [Abstract][Full Text] [Related]
19. The oral adverse effects of isotretinoin treatment in acne vulgaris patients: A prospective, case-control study.
Erdemir U; Okan G; Gungor S; Tekin B; Yildiz SO; Yildiz E
Niger J Clin Pract; 2017 Jul; 20(7):860-866. PubMed ID: 28791981
[TBL] [Abstract][Full Text] [Related]
20. The effect of oral isotretinoin on visual contrast sensitivity and amount of lacrimation in patients with acne vulgaris.
Polat M; Kükner Ş
Cutan Ocul Toxicol; 2017 Mar; 36(1):35-38. PubMed ID: 26911891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
